GIGYF2 has no major role in Parkinson genetic etiology in a Belgian population

Neurobiology of Aging

Volumn 32, Issue 2, 2011, Pages 308-312

  Meeus, Bram ^a,b,c   Nuytemans, Karen ^a,b,c   Crosiers, David ^a,b,c,d   Engelborghs, Sebastiaan ^b,c,d   Pals, Philippe ^b,c,d   Pickut, Barbara ^d   Peeters, Karin ^a,b,c   Mattheijssens, Maria ^a,b,c   Corsmit, Ellen ^a,b,c   Cras, Patrick ^b,c,d   De Deyn, Peter Paul ^b,c,d   Theuns, Jessie ^a,b,c   Van Broeckhoven Christine, C ^a,b,c  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c UNIVERSITY OF ANTWERP   (Belgium)

^d ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Chromosome 2; GIGYF2; Mutations; PARK11; Parkinson

Indexed keywords

ARGININE; BINDING PROTEIN; CYSTEINE; GLUTAMINE; GROWTH FACTOR RECEPTOR BOUND PROTEIN 10 INTERACTING GYF PROTEIN 2; LEVODOPA; TYROSINE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BELGIUM; CONTROLLED STUDY; DRUG RESPONSE; EXON; FEMALE; GENE SEQUENCE; GENETIC VARIABILITY; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; PRIORITY JOURNAL;

ADULT; AGED; BELGIUM; CARRIER PROTEINS; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; MUTATION; PARKINSON DISEASE;

EID: 78649902578     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2009.02.016     Document Type: Article

References (29)

1. Baba M., Nakajo S., Tu P.H., Tomita T., Nakaya K., Lee V.M., Trojanowski J.Q., Iwatsubo T. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am. J. Pathol. 1998, 152:879-884.
2. Bogaerts V., Nuytemans K., Reumers J., Pals P., Engelborghs S., Pickut B., Corsmit E., Peeters K., Schymkowitz J., De Deyn P.P., Cras P., Rousseau F., Theuns J., Van Broeckhoven C. Genetic variability in the mitochondrial serine protease HTRA2 contributes to risk for Parkinson disease. Hum. Mutat. 2008, 29:832-840.
3. Bonifati V., Rizzu P., van Baren M.J., Schaap O., Breedveld G.J., Krieger E., Dekker M.C., Squitieri F., Ibanez P., Joosse M., van Dongen J.W., Vanacore N., van Swieten J.C., Brice A., Meco G., van Duijn C.M., Oostra B.A., Heutink P. Mutations in the DJ-1 gene associated with autosomal recessive early onset parkinsonism. Science 2003, 299:256-259.
4. Bras J., Simón-Sánchez J., Federoff M., Morgadinho A., Januario C., Ribeiro M., Cunha L., Oliveira C., Singleton A.B. Lack of replication of association between GIGYF2 variants and Parkinson disease. Hum Mol Genet. 2009, 18:341-346.
5. de Rijk M.C., Launer L.J., Berger K., Breteler M.M., Dartigues J.F., Baldereschi M., Fratiglioni L., Lobo A., Martinez-Lage J., Trenkwalder C., Hofman A. Prevalence of Parkinson's disease in Europe: a collaborative study of population-based cohorts. Neurologic diseases in the elderly research group. Neurology 2000, 54:S21-S23.
6. Engelborghs S., Dermaut B., Goeman J., Saerens J., Marien P., Pickut B.A., Van den B.M., Serneels S., Cruts M., Van Broeckhoven C., De Deyn P.P. Prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effects. J. Neurol. Neurosurg. Psychiatry 2003, 74:1148-1151.
7. Farrer M.J. Genetics of Parkinson disease: paradigm shifts and future prospects. Nat. Rev. Genet. 2006, 7:306-318.
8. Ferrer-Costa C., Gelpi J.L., Zamakola L., Parraga I., de la Cruz X., Orozco M. PMUT: a web-based tool for the annotation of pathological mutations on proteins. Bioinformatics 2005, 21:3176-3178.
9. Giovannone B., Lee E., Laviola L., Giorgino F., Cleveland K.A., Smith R.J. Two novel proteins that are linked to insulin-like growth factor (IGF-I) receptors by the Grb10 adapter and modulate IGF-I signaling. J. Biol. Chem. 2003, 278:31564-31573.
10. Healy D.G., Abou-Sleiman P.M., Casas J.P., Ahmadi K.R., Lynch T., Gandhi S., Muqit M.M., Foltynie T., Barker R., Bhatia K.P., Quinn N.P., Lees A.J., Gibson J.M., Holton J.L., Revesz T., Goldstein D.B., Wood N.W. UCHL-1 is not a Parkinson's disease susceptibility gene. Ann. Neurol. 2006, 59:627-633.
11. Kitada T., Asakawa S., Hattori N., Matsumine H., Yamamura Y., Minoshima S., Yokochi M., Mizuno Y., Shimizu N. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998, 392:605-608.
12. Lautier C., Goldwurm S., Durr A., Giovannone B., Tsiaras W.G., Pezzoli G., Brice A., Smith R.J. Mutations in the GIGYF2 (TNRC15) gene at the PARK11 locus in familial Parkinson disease. Am. J. Hum. Genet. 2008, 82:822-833.
13. Le W.D., Xu P., Jankovic J., Jiang H., Appel S.H., Smith R.G., Vassilatis D.K. Mutations in NR4A2 associated with familial Parkinson disease. Nat. Genet. 2003, 33:85-89.
14. Lincoln S., Vaughan J., Wood N., Baker M., Adamson J., Gwinn-Hardy K., Lynch T., Hardy J., Farrer M. Low frequency of pathogenic mutations in the ubiquitin carboxy-terminal hydrolase gene in familial Parkinson's disease. Neuroreport 1999, 10:427-429.
15. Marx F.P., Holzmann C., Strauss K.M., Li L., Eberhardt O., Gerhardt E., Cookson M.R., Hernandez D., Farrer M.J., Kachergus J., Engelender S., Ross C.A., Berger K., Schols L., Schulz J.B., Riess O., Kruger R. Identification and functional characterization of a novel R621C mutation in the synphilin-1 gene in Parkinson's disease. Hum. Mol. Genet. 2003, 12:1223-1231.
16. Ng P.C., Henikoff S. SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res. 2003, 31:3812-3814.
17. Nuytemans, K., Brouwers, N., Meeus, B., Goossens, D., Engelborghs, S., Pals, P., Pickut, B., Van den Broeck, M., Corsmit, E., Cras, P., De Deyn, P.P., Del-Favero, J., Van Broeckhoven, C., Theuns, J., in press. Relative contribution of simple mutations versus copy number variations in five PD genes in Belgian Parkinson's disease patients. Hum. Mutat.
18. Paisan-Ruiz C., Jain S., Evans E.W., Gilks W.P., Simon J., van der B.M., de Munain A.L., Aparicio S., Gil A.M., Khan N., Johnson J., Martinez J.R., Nicholl D., Carrera I.M., Pena A.S., de Silva R., Lees A., Marti-Masso J.F., Perez-Tur J., Wood N.W., Singleton A.B. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 2004, 44:595-600.
19. Pals P., Van Everbroeck B., Grubben B., Viaene M.K., Dom R., van der L.C., Santens P., Martin J.J., Cras P. Case-control study of environmental risk factors for Parkinson's disease in Belgium. Eur. J. Epidemiol. 2003, 18:1133-1142.
20. Pankratz N., Nichols W.C., Uniacke S.K., Halter C., Rudolph A., Shults C., Conneally P.M., Foroud T. Genome screen to identify susceptibility genes for Parkinson disease in a sample without parkin mutations. Am. J. Hum. Genet. 2002, 71:124-135.
21. Pankratz N., Nichols W.C., Uniacke S.K., Halter C., Rudolph A., Shults C., Conneally P.M., Foroud T. Significant linkage of Parkinson disease to chromosome 2q36-37. Am. J. Hum. Genet. 2003, 72:1053-1057.
22. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E.S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W.G., Lazzarini A.M., Duvoisin R.C., Di Iorio G., Golbe L.I., Nussbaum R.L. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997, 276:2045-2047.
23. Ramirez A., Heimbach A., Grundemann J., Stiller B., Hampshire D., Cid L.P., Goebel I., Mubaidin A.F., Wriekat A.L., Roeper J., Al Din A., Hillmer A.M., Karsak M., Liss B., Woods C.G., Behrens M.I., Kubisch C. Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat. Genet. 2006, 38:1184-1191.
24. Simon-Sanchez J., Singleton A.B. Sequencing analysis of OMI/HTRA2 shows previously reported pathogenic mutations in neurologically normal controls. Hum. Mol. Genet. 2008, 17:1988-1993.
25. Strauss K.M., Martins L.M., Plun-Favreau H., Marx F.P., Kautzmann S., Berg D., Gasser T., Wszolek Z., Muller T., Bornemann A., Wolburg H., Downward J., Riess O., Schulz J.B., Kruger R. Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease. Hum. Mol. Genet. 2005, 14:2099-2111.
26. Sutherland G.T., Siebert G.A., Newman J.R., Silburn P.A., Boyle R.S., O'Sullivan J.D., Mellick G.D. Haplotype analysis of the PARK 11 gene, GIGYF2, in sporadic Parkinson's disease. Mov. Disord. 2009, 24:448-452.
27. Valente E.M., Abou-Sleiman P.M., Caputo V., Muqit M.M., Harvey K., Gispert S., Ali Z., Del Turco D., Bentivoglio A.R., Healy D.G., Albanese A., Nussbaum R., Gonzalez-Maldonado R., Deller T., Salvi S., Cortelli P., Gilks W.P., Latchman D.S., Harvey R.J., Dallapiccola B., Auburger G., Wood N.W. Hereditary early onset Parkinson's disease caused by mutations in PINK1. Science 2004, 304:1158-1160.
28. Vilarino-Guell C., Ross O.A., Soto A.I., Farrer M.J., Haugarvoll K., Aasly J.O., Uitti R.J., Wszolek Z.K. Reported mutations in GIGYF2 are not a common cause of Parkinson's disease. Mov. Disord. 2009.
29. Weckx S., Del Favero J., Rademakers R., Claes L., Cruts M., De Jonghe P., Van Broeckhoven C., De Rijk P. novoSNP, a novel computational tool for sequence variation discovery. Genome Res. 2005, 15:436-442.